SCHEMBL6555250

SCHEMBL6555250

CCOc1cc(Cc2cnc(N)nc2N)cc(OC2CCC(C#N)C2)c1-c1ccc(O)cc1

nearest known ligand 0.48

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DHFR P00374 4/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6555311 0.89 DHFR (0.44) DHFR
SCHEMBL6557186 0.89 DHFR (0.44) DHFR
SCHEMBL6557337 0.88 DHFR (0.50) DHFR
SCHEMBL6555435 0.87 DHFR (0.50) DHFR
SCHEMBL6556769 0.87 DHFR (0.50) DHFR
SCHEMBL6556693 0.84 DHFR (0.61) DHFR
SCHEMBL6556388 0.82 DHFR (0.52) DHFR
SCHEMBL6557320 0.82 DHFR (0.45) DHFR
SCHEMBL6555220 0.81 DHFR (0.49) DHFR
SCHEMBL6555219 0.81 DHFR (0.49) DHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1230224-B1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES BASILEA PHARMACEUTICA AG (CH) 2004-12-29 EP disclosed
US-6821980-B1 Substituted 5-benzyl-2,4-diaminopyrimidines BASILEA PHARMACEUTICA AG (CH) 2004-11-23 US disclosed
EP-1230224-A1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES F. HOFFMANN-LA ROCHE AG (CH) 2002-08-14 EP disclosed
WO-2001032633-A1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES BASILEA PHARMACEUTICA AG (CH) 2001-05-10 WO disclosed